logo

Galectin Therapeutics Inc (GALT)



Trade GALT now with
  Date
  Headline
3/29/2018 8:14:07 AM Galectin Therapeutics FY Net Loss Applicable To Common Stockholders $17.5 Mln Or $0.49 Per Share
1/25/2018 8:37:34 AM Galectin Receives Patents In China And Japan That Support NASH And Cancer Immunotherapy Clinical Development Programs
  
 
>